BLS vs EMV

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

EMV

EMVISION FPO [EMV]

54MEDIUM

Score Breakdown

BLS EMV
Technical
49
42
Catalyst
55
51
Sentiment
50
50
Fundamental
96
70
Momentum
84
39
Risk Gate
50
50

Key Metrics

BLS Metric EMV
$193.2MMarket Cap$150.6M
218KAvg Volume (20d)41K
+0.0%Short InterestN/A
$1.10052-Week High$2.430
$0.33052-Week Low$1.470
+1.8%Daily Change-0.3%
$0.855Reference Price$1.635
+66.1%ROE-58.0%
+18.7%Profit Margin-188.0%

Active Signals

BLS Signals

●MACD momentum is losing steam
●Drifting lower — down 8.1% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (4.0x)
●Strong revenue growth (+150%)
●Piotroski F-Score strong (8/9, low-confidence approx)

EMV Signals

●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Drifting lower — down 3.5% over the last 5 days
●Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (8 quarters)
●4C filed 2026-07-14
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+6pts)

Ask Scout AI to compare BLS and EMV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs IDX →BLS vs LGP →BLS vs LTP →BLS vs MYX →BLS vs NSB →
BLS Full Analysis → EMV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).